Lakeland Industries, Inc. (NASDAQ:LAKE) Receives $15.20 Average PT from Analysts

Lakeland Industries, Inc. (NASDAQ:LAKE) has been given a consensus recommendation of “Hold” by the five brokerages that are currently covering the firm, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell recommendation, one has issued a hold recommendation and three have assigned a buy recommendation to the company. The average 1 year price objective among brokers that have covered the stock in the last year is $15.20.

LAKE has been the topic of a number of research analyst reports. Weiss Ratings reaffirmed a “sell (d)” rating on shares of Lakeland Industries in a research note on Thursday, January 22nd. Maxim Group set a $16.00 price target on Lakeland Industries in a research note on Monday, April 20th. DA Davidson raised Lakeland Industries from a “neutral” rating to a “buy” rating and lifted their price target for the stock from $10.00 to $14.00 in a research note on Monday, April 20th. Zacks Research raised Lakeland Industries from a “strong sell” rating to a “hold” rating in a research note on Monday, February 9th. Finally, Lake Street Capital lowered their price target on Lakeland Industries from $16.00 to $13.00 and set a “buy” rating on the stock in a research note on Friday, April 17th.

Hedge Funds Weigh In On Lakeland Industries

A number of institutional investors and hedge funds have recently added to or reduced their stakes in LAKE. Pacific Ridge Capital Partners LLC boosted its stake in Lakeland Industries by 62.3% during the fourth quarter. Pacific Ridge Capital Partners LLC now owns 772,015 shares of the medical instruments supplier’s stock worth $6,825,000 after buying an additional 296,222 shares during the last quarter. Kennedy Capital Management LLC acquired a new position in Lakeland Industries during the third quarter worth $2,287,000. Geode Capital Management LLC boosted its stake in Lakeland Industries by 115.9% during the second quarter. Geode Capital Management LLC now owns 217,786 shares of the medical instruments supplier’s stock worth $2,964,000 after buying an additional 116,901 shares during the last quarter. Royce & Associates LP boosted its stake in Lakeland Industries by 10.0% during the third quarter. Royce & Associates LP now owns 1,178,670 shares of the medical instruments supplier’s stock worth $17,444,000 after buying an additional 107,100 shares during the last quarter. Finally, Peapod Lane Capital LLC acquired a new position in shares of Lakeland Industries in the 4th quarter valued at $604,000. Institutional investors and hedge funds own 71.69% of the company’s stock.

Lakeland Industries Price Performance

Shares of NASDAQ LAKE opened at $10.57 on Friday. The company has a debt-to-equity ratio of 0.24, a quick ratio of 1.36 and a current ratio of 3.53. The company has a market cap of $104.22 million, a PE ratio of -4.10 and a beta of 1.45. The business has a 50-day simple moving average of $9.25 and a two-hundred day simple moving average of $10.51. Lakeland Industries has a fifty-two week low of $7.15 and a fifty-two week high of $20.50.

About Lakeland Industries

Lakeland Industries, Inc (NASDAQ:LAKE) is a global provider of high-performance protective apparel and accessories designed to safeguard workers in industrial, healthcare, laboratory, and emergency response environments. The company’s expertise lies in producing garments that shield against chemical, biological, radiological, and thermal risks, supporting safety protocols in sectors such as oil and gas, petrochemicals, pharmaceuticals, and first responders.

The product portfolio encompasses both single-use and reusable solutions, including chemical protective coveralls, flame-resistant garments, arc flash clothing, medical isolation gowns, and cleanroom suits.